Quotient Investors’s PDL BioPharma, Inc. PDLI Stock Holding History

Quotient Investors’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$88K	Buy	+26,000	New	+$72.3K	0.06%	140
2016 Q4	–	Sell	-41,300	Closed	-$138K	–	205
2016 Q3	$138K	Sell	41,300 -34,700	-46%	-$110K	0.09%	167
2016 Q2	$239K	Buy	76,000 +100	+0.1%	+$333	0.11%	188
2016 Q1	$253K	Sell	75,900 -100	-0.1%	-$312	0.09%	188
2015 Q4	$269K	Buy	76,000 +18,189	+31%	+$76.1K	0.1%	187
2015 Q3	$291K	Sell	57,811 -13,389	-19%	-$76.7K	0.06%	160
2015 Q2	$458K	Buy	71,200 +1,100	+2%	+$7.37K	0.06%	174
2015 Q1	$493K	Buy	70,100 +7,700	+12%	+$55.8K	0.07%	168
2014 Q4	$481K	Sell	62,400 -7,100	-10%	-$56.2K	0.1%	167
2014 Q3	$519K	Buy	69,500 +43,700	+169%	+$406K	0.11%	156
2014 Q2	$250K	Buy	+25,800	New	+$230K	0.05%	223

Other funds holding PDLI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Quotient Investors's PDLI Position: Q3 2017 in Review

Quotient Investors opened a new position in PDL BioPharma, Inc. (PDLI) in Q3 2017: 26,000 shares worth $88K. The stake represents 0.06% of the portfolio and ranks #140 among its holdings. This is a return to the name: Quotient Investors previously reported a position in PDLI as recently as Q3 2016.

Quotient Investors first reported a position in PDLI in Q2 2014 and has held it in 11 quarters since. The position peaked at $519K in Q3 2014. 186 funds tracked by Wall St. Rank hold PDLI as of Q3 2017.

Quotient Investors held 26,000 shares of PDL BioPharma, Inc. worth $88K as of Q3 2017.
PDL BioPharma, Inc. was a new Quotient Investors position in Q3 2017.
PDL BioPharma, Inc. made up 0.06% of Quotient Investors's portfolio in Q3 2017, its #140 holding.
Quotient Investors first reported a position in PDL BioPharma, Inc. in Q2 2014 and has held it in 11 quarters since.
Quotient Investors's PDL BioPharma, Inc. position peaked at $519K in Q3 2014.
186 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2017.

Based on Quotient Investors's 13F filing for Q3 2017, filed 18 Oct 2017.